This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Lifshitz & Miller Law Firm Announces Investigation Of Imperva, Inc., OBA Financial Services, Inc., Och-Ziff Capital Management Group LLC, Questcor Pharmaceuticals, Inc., Vocus, Inc. And Zygo Corporation

NEW YORK, April 11, 2014 /PRNewswire/ --

Imperva, Inc.  

Lifshitz & Miller announces that it is investigating potential claims against the board of Imperva, Inc. ("IMPV").  On April 9, 2014, Imperva announced that it expects to report total revenue for the first quarter of 2014 in the range of $31.0 million to $31.5 million compared to the company's prior guidance of total revenue in the range of $36.0 million to $37.0 million.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

OBA Financial Services, Inc.

Lifshitz & Miller  announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of OBA Financial Services, Inc. ("OBAF") to F.N.B. Corporation in an all stock transaction valued at approximately $23.56 per share, or $94 million in the aggregate.

Lifshitz & Miller's investigation is focused on whether the OBAF directors are acting in shareholders best interest.

For information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Och-Ziff Capital Management Group LLC

Lifshitz & Miller  announces that it is investigating potential claims against the officers and board of Och-Ziff Capital Management Group LLC ("OZM").  On March 18, 2014, the Company disclosed that starting in 2011, U.S. regulators were investigating whether Och-Ziff broke bribery laws in accepting an investment from a sovereign wealth fund.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Questcor Pharmaceuticals, Inc.

Lifshitz & Miller  announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Questcor Pharmaceuticals, Inc. ("QCOR") to Mallinckrodt plc in a cash and stock transaction valued at approximately $5.6 billion or approximate consideration of $86.10 per Questcor share.

Lifshitz & Miller's investigation is focused on whether the QCOR directors are acting in shareholders best interest.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs